BioMerieux to pay $450M for infectious disease Dx firm

France-based bioMerieux has agreed to buy BioFire Diagnostics, maker of the PCR FilmArray used to detect infectious diseases, for $450 million plus debt. The deal, set to be finalized at the close of the fiscal year or early next year, is expected to allow bioMerieux to bolster its presence in the infectious disease testing arena.

View Full Article in:

American City Business Journals · WRALTechWire.com (Raleigh, N.C.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ